 | • レポートコード：MRC2-11QY02069 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は日光角化症治療のグローバル市場について調査・分析したレポートです。種類別（854-A、ACT-01、AD-17137、セレコキシブ、DFD-08、GDC-695、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別日光角化症治療の競争状況、市場シェア ・世界の日光角化症治療市場：種類別市場規模 2015年-2020年（854-A、ACT-01、AD-17137、セレコキシブ、DFD-08、GDC-695、その他） ・世界の日光角化症治療市場：種類別市場規模予測 2021年-2026年（854-A、ACT-01、AD-17137、セレコキシブ、DFD-08、GDC-695、その他） ・世界の日光角化症治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の日光角化症治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の日光角化症治療市場分析：米国、カナダ ・ヨーロッパの日光角化症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの日光角化症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の日光角化症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの日光角化症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：3M Drug Delivery Systems、Athenex Inc、CritiTech Inc、Foamix Pharmaceuticals Ltd、G&E Herbal Biotechnology Co Ltd、Galderma SA、Laboratories Ojer Pharma SL、LEO Pharma A/S、Novartis AG、Oncology Research International Ltd、Promius Pharma LLC、Valeant Pharmaceuticals International Inc、Vectura Group Plc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Actinic (Solar) Keratosis Treatment Market
The global Actinic (Solar) Keratosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Actinic (Solar) Keratosis Treatment Scope and Market Size
Actinic (Solar) Keratosis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Actinic (Solar) Keratosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Actinic (Solar) Keratosis Treatment market is segmented into
854-A
ACT-01
AD-17137
Celecoxib
DFD-08
GDC-695
Others
Segment by Application, the Actinic (Solar) Keratosis Treatment market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Actinic (Solar) Keratosis Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Actinic (Solar) Keratosis Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Actinic (Solar) Keratosis Treatment Market Share Analysis
Actinic (Solar) Keratosis Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Actinic (Solar) Keratosis Treatment business, the date to enter into the Actinic (Solar) Keratosis Treatment market, Actinic (Solar) Keratosis Treatment product introduction, recent developments, etc.
The major vendors covered:
3M Drug Delivery Systems
Athenex Inc
CritiTech Inc
Foamix Pharmaceuticals Ltd
G&E Herbal Biotechnology Co Ltd
Galderma SA
Laboratories Ojer Pharma SL
LEO Pharma A/S
Novartis AG
Oncology Research International Ltd
Promius Pharma LLC
Valeant Pharmaceuticals International Inc
Vectura Group Plc
1 Study Coverage
1.1 Actinic (Solar) Keratosis Treatment Product Introduction
1.2 Market Segments
1.3 Key Actinic (Solar) Keratosis Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Actinic (Solar) Keratosis Treatment Market Size Growth Rate by Type
1.4.2 854-A
1.4.3 ACT-01
1.4.4 AD-17137
1.4.5 Celecoxib
1.4.6 DFD-08
1.4.7 GDC-695
1.4.8 Others
1.5 Market by Application
1.5.1 Global Actinic (Solar) Keratosis Treatment Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Actinic (Solar) Keratosis Treatment Market Size, Estimates and Forecasts
2.1.1 Global Actinic (Solar) Keratosis Treatment Revenue 2015-2026
2.1.2 Global Actinic (Solar) Keratosis Treatment Sales 2015-2026
2.2 Global Actinic (Solar) Keratosis Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Actinic (Solar) Keratosis Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Actinic (Solar) Keratosis Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Actinic (Solar) Keratosis Treatment Competitor Landscape by Players
3.1 Actinic (Solar) Keratosis Treatment Sales by Manufacturers
3.1.1 Actinic (Solar) Keratosis Treatment Sales by Manufacturers (2015-2020)
3.1.2 Actinic (Solar) Keratosis Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Actinic (Solar) Keratosis Treatment Revenue by Manufacturers
3.2.1 Actinic (Solar) Keratosis Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Actinic (Solar) Keratosis Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Actinic (Solar) Keratosis Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Actinic (Solar) Keratosis Treatment Revenue in 2019
3.2.5 Global Actinic (Solar) Keratosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Actinic (Solar) Keratosis Treatment Price by Manufacturers
3.4 Actinic (Solar) Keratosis Treatment Manufacturing Base Distribution, Product Types
3.4.1 Actinic (Solar) Keratosis Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Actinic (Solar) Keratosis Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Actinic (Solar) Keratosis Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Actinic (Solar) Keratosis Treatment Market Size by Type (2015-2020)
4.1.1 Global Actinic (Solar) Keratosis Treatment Sales by Type (2015-2020)
4.1.2 Global Actinic (Solar) Keratosis Treatment Revenue by Type (2015-2020)
4.1.3 Actinic (Solar) Keratosis Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Actinic (Solar) Keratosis Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Actinic (Solar) Keratosis Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Actinic (Solar) Keratosis Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Actinic (Solar) Keratosis Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Actinic (Solar) Keratosis Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Actinic (Solar) Keratosis Treatment Market Size by Application (2015-2020)
5.1.1 Global Actinic (Solar) Keratosis Treatment Sales by Application (2015-2020)
5.1.2 Global Actinic (Solar) Keratosis Treatment Revenue by Application (2015-2020)
5.1.3 Actinic (Solar) Keratosis Treatment Price by Application (2015-2020)
5.2 Actinic (Solar) Keratosis Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Actinic (Solar) Keratosis Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Actinic (Solar) Keratosis Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Actinic (Solar) Keratosis Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Actinic (Solar) Keratosis Treatment by Country
6.1.1 North America Actinic (Solar) Keratosis Treatment Sales by Country
6.1.2 North America Actinic (Solar) Keratosis Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Actinic (Solar) Keratosis Treatment Market Facts & Figures by Type
6.3 North America Actinic (Solar) Keratosis Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Actinic (Solar) Keratosis Treatment by Country
7.1.1 Europe Actinic (Solar) Keratosis Treatment Sales by Country
7.1.2 Europe Actinic (Solar) Keratosis Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Actinic (Solar) Keratosis Treatment Market Facts & Figures by Type
7.3 Europe Actinic (Solar) Keratosis Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Actinic (Solar) Keratosis Treatment by Region
8.1.1 Asia Pacific Actinic (Solar) Keratosis Treatment Sales by Region
8.1.2 Asia Pacific Actinic (Solar) Keratosis Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Actinic (Solar) Keratosis Treatment Market Facts & Figures by Type
8.3 Asia Pacific Actinic (Solar) Keratosis Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Actinic (Solar) Keratosis Treatment by Country
9.1.1 Latin America Actinic (Solar) Keratosis Treatment Sales by Country
9.1.2 Latin America Actinic (Solar) Keratosis Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Actinic (Solar) Keratosis Treatment Market Facts & Figures by Type
9.3 Central & South America Actinic (Solar) Keratosis Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Actinic (Solar) Keratosis Treatment by Country
10.1.1 Middle East and Africa Actinic (Solar) Keratosis Treatment Sales by Country
10.1.2 Middle East and Africa Actinic (Solar) Keratosis Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Actinic (Solar) Keratosis Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Actinic (Solar) Keratosis Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 3M Drug Delivery Systems
11.1.1 3M Drug Delivery Systems Corporation Information
11.1.2 3M Drug Delivery Systems Description and Business Overview
11.1.3 3M Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3M Drug Delivery Systems Actinic (Solar) Keratosis Treatment Products Offered
11.1.5 3M Drug Delivery Systems Related Developments
11.2 Athenex Inc
11.2.1 Athenex Inc Corporation Information
11.2.2 Athenex Inc Description and Business Overview
11.2.3 Athenex Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Athenex Inc Actinic (Solar) Keratosis Treatment Products Offered
11.2.5 Athenex Inc Related Developments
11.3 CritiTech Inc
11.3.1 CritiTech Inc Corporation Information
11.3.2 CritiTech Inc Description and Business Overview
11.3.3 CritiTech Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CritiTech Inc Actinic (Solar) Keratosis Treatment Products Offered
11.3.5 CritiTech Inc Related Developments
11.4 Foamix Pharmaceuticals Ltd
11.4.1 Foamix Pharmaceuticals Ltd Corporation Information
11.4.2 Foamix Pharmaceuticals Ltd Description and Business Overview
11.4.3 Foamix Pharmaceuticals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Foamix Pharmaceuticals Ltd Actinic (Solar) Keratosis Treatment Products Offered
11.4.5 Foamix Pharmaceuticals Ltd Related Developments
11.5 G&E Herbal Biotechnology Co Ltd
11.5.1 G&E Herbal Biotechnology Co Ltd Corporation Information
11.5.2 G&E Herbal Biotechnology Co Ltd Description and Business Overview
11.5.3 G&E Herbal Biotechnology Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 G&E Herbal Biotechnology Co Ltd Actinic (Solar) Keratosis Treatment Products Offered
11.5.5 G&E Herbal Biotechnology Co Ltd Related Developments
11.6 Galderma SA
11.6.1 Galderma SA Corporation Information
11.6.2 Galderma SA Description and Business Overview
11.6.3 Galderma SA Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Galderma SA Actinic (Solar) Keratosis Treatment Products Offered
11.6.5 Galderma SA Related Developments
11.7 Laboratories Ojer Pharma SL
11.7.1 Laboratories Ojer Pharma SL Corporation Information
11.7.2 Laboratories Ojer Pharma SL Description and Business Overview
11.7.3 Laboratories Ojer Pharma SL Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Laboratories Ojer Pharma SL Actinic (Solar) Keratosis Treatment Products Offered
11.7.5 Laboratories Ojer Pharma SL Related Developments
11.8 LEO Pharma A/S
11.8.1 LEO Pharma A/S Corporation Information
11.8.2 LEO Pharma A/S Description and Business Overview
11.8.3 LEO Pharma A/S Sales, Revenue and Gross Margin (2015-2020)
11.8.4 LEO Pharma A/S Actinic (Solar) Keratosis Treatment Products Offered
11.8.5 LEO Pharma A/S Related Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Description and Business Overview
11.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis AG Actinic (Solar) Keratosis Treatment Products Offered
11.9.5 Novartis AG Related Developments
11.10 Oncology Research International Ltd
11.10.1 Oncology Research International Ltd Corporation Information
11.10.2 Oncology Research International Ltd Description and Business Overview
11.10.3 Oncology Research International Ltd Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Oncology Research International Ltd Actinic (Solar) Keratosis Treatment Products Offered
11.10.5 Oncology Research International Ltd Related Developments
11.1 3M Drug Delivery Systems
11.1.1 3M Drug Delivery Systems Corporation Information
11.1.2 3M Drug Delivery Systems Description and Business Overview
11.1.3 3M Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3M Drug Delivery Systems Actinic (Solar) Keratosis Treatment Products Offered
11.1.5 3M Drug Delivery Systems Related Developments
11.12 Valeant Pharmaceuticals International Inc
11.12.1 Valeant Pharmaceuticals International Inc Corporation Information
11.12.2 Valeant Pharmaceuticals International Inc Description and Business Overview
11.12.3 Valeant Pharmaceuticals International Inc Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Valeant Pharmaceuticals International Inc Products Offered
11.12.5 Valeant Pharmaceuticals International Inc Related Developments
11.13 Vectura Group Plc
11.13.1 Vectura Group Plc Corporation Information
11.13.2 Vectura Group Plc Description and Business Overview
11.13.3 Vectura Group Plc Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Vectura Group Plc Products Offered
11.13.5 Vectura Group Plc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Actinic (Solar) Keratosis Treatment Market Estimates and Projections by Region
12.1.1 Global Actinic (Solar) Keratosis Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Actinic (Solar) Keratosis Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Actinic (Solar) Keratosis Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Actinic (Solar) Keratosis Treatment Sales Forecast (2021-2026)
12.2.2 North America: Actinic (Solar) Keratosis Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Actinic (Solar) Keratosis Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Actinic (Solar) Keratosis Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Actinic (Solar) Keratosis Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Actinic (Solar) Keratosis Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Actinic (Solar) Keratosis Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Actinic (Solar) Keratosis Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Actinic (Solar) Keratosis Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Actinic (Solar) Keratosis Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Actinic (Solar) Keratosis Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Actinic (Solar) Keratosis Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Actinic (Solar) Keratosis Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Actinic (Solar) Keratosis Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Actinic (Solar) Keratosis Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Actinic (Solar) Keratosis Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Actinic (Solar) Keratosis Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Actinic (Solar) Keratosis Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Actinic (Solar) Keratosis Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Actinic (Solar) Keratosis Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Actinic (Solar) Keratosis Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Actinic (Solar) Keratosis Treatment Market Segments
Table 2. Ranking of Global Top Actinic (Solar) Keratosis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Actinic (Solar) Keratosis Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 854-A
Table 5. Major Manufacturers of ACT-01
Table 6. Major Manufacturers of AD-17137
Table 7. Major Manufacturers of Celecoxib
Table 8. Major Manufacturers of DFD-08
Table 9. Major Manufacturers of GDC-695
Table 10. Major Manufacturers of Others
Table 11. Global Actinic (Solar) Keratosis Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Actinic (Solar) Keratosis Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Actinic (Solar) Keratosis Treatment Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Actinic (Solar) Keratosis Treatment Sales Market Share by Regions (2015-2020)
Table 15. Global Actinic (Solar) Keratosis Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Actinic (Solar) Keratosis Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Actinic (Solar) Keratosis Treatment Sales Share by Manufacturers (2015-2020)
Table 18. Global Actinic (Solar) Keratosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Actinic (Solar) Keratosis Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Actinic (Solar) Keratosis Treatment as of 2019)
Table 20. Actinic (Solar) Keratosis Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Actinic (Solar) Keratosis Treatment Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Actinic (Solar) Keratosis Treatment Price (2015-2020) (USD/Pcs)
Table 23. Actinic (Solar) Keratosis Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Actinic (Solar) Keratosis Treatment Product Type
Table 25. Date of International Manufacturers Enter into Actinic (Solar) Keratosis Treatment Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Actinic (Solar) Keratosis Treatment Sales by Type (2015-2020) (K Pcs)
Table 28. Global Actinic (Solar) Keratosis Treatment Sales Share by Type (2015-2020)
Table 29. Global Actinic (Solar) Keratosis Treatment Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Actinic (Solar) Keratosis Treatment Revenue Share by Type (2015-2020)
Table 31. Actinic (Solar) Keratosis Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Actinic (Solar) Keratosis Treatment Sales by Application (2015-2020) (K Pcs)
Table 33. Global Actinic (Solar) Keratosis Treatment Sales Share by Application (2015-2020)
Table 34. North America Actinic (Solar) Keratosis Treatment Sales by Country (2015-2020) (K Pcs)
Table 35. North America Actinic (Solar) Keratosis Treatment Sales Market Share by Country (2015-2020)
Table 36. North America Actinic (Solar) Keratosis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Actinic (Solar) Keratosis Treatment Revenue Market Share by Country (2015-2020)
Table 38. North America Actinic (Solar) Keratosis Treatment Sales by Type (2015-2020) (K Pcs)
Table 39. North America Actinic (Solar) Keratosis Treatment Sales Market Share by Type (2015-2020)
Table 40. North America Actinic (Solar) Keratosis Treatment Sales by Application (2015-2020) (K Pcs)
Table 41. North America Actinic (Solar) Keratosis Treatment Sales Market Share by Application (2015-2020)
Table 42. Europe Actinic (Solar) Keratosis Treatment Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Actinic (Solar) Keratosis Treatment Sales Market Share by Country (2015-2020)
Table 44. Europe Actinic (Solar) Keratosis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Actinic (Solar) Keratosis Treatment Revenue Market Share by Country (2015-2020)
Table 46. Europe Actinic (Solar) Keratosis Treatment Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Actinic (Solar) Keratosis Treatment Sales Market Share by Type (2015-2020)
Table 48. Europe Actinic (Solar) Keratosis Treatment Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Actinic (Solar) Keratosis Treatment Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Actinic (Solar) Keratosis Treatment Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Actinic (Solar) Keratosis Treatment Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Actinic (Solar) Keratosis Treatment Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Actinic (Solar) Keratosis Treatment Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Actinic (Solar) Keratosis Treatment Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Actinic (Solar) Keratosis Treatment Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Actinic (Solar) Keratosis Treatment Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Actinic (Solar) Keratosis Treatment Sales Market Share by Application (2015-2020)
Table 58. Latin America Actinic (Solar) Keratosis Treatment Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Actinic (Solar) Keratosis Treatment Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Actinic (Solar) Keratosis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Actinic (Solar) Keratosis Treatment Revenue Market Share by Country (2015-2020)
Table 62. Latin America Actinic (Solar) Keratosis Treatment Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Actinic (Solar) Keratosis Treatment Sales Market Share by Type (2015-2020)
Table 64. Latin America Actinic (Solar) Keratosis Treatment Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Actinic (Solar) Keratosis Treatment Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Actinic (Solar) Keratosis Treatment Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Actinic (Solar) Keratosis Treatment Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Actinic (Solar) Keratosis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Actinic (Solar) Keratosis Treatment Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Actinic (Solar) Keratosis Treatment Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Actinic (Solar) Keratosis Treatment Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Actinic (Solar) Keratosis Treatment Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Actinic (Solar) Keratosis Treatment Sales Market Share by Application (2015-2020)
Table 74. 3M Drug Delivery Systems Corporation Information
Table 75. 3M Drug Delivery Systems Description and Major Businesses
Table 76. 3M Drug Delivery Systems Actinic (Solar) Keratosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. 3M Drug Delivery Systems Product
Table 78. 3M Drug Delivery Systems Recent Development
Table 79. Athenex Inc Corporation Information
Table 80. Athenex Inc Description and Major Businesses
Table 81. Athenex Inc Actinic (Solar) Keratosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Athenex Inc Product
Table 83. Athenex Inc Recent Development
Table 84. CritiTech Inc Corporation Information
Table 85. CritiTech Inc Description and Major Businesses
Table 86. CritiTech Inc Actinic (Solar) Keratosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. CritiTech Inc Product
Table 88. CritiTech Inc Recent Development
Table 89. Foamix Pharmaceuticals Ltd Corporation Information
Table 90. Foamix Pharmaceuticals Ltd Description and Major Businesses
Table 91. Foamix Pharmaceuticals Ltd Actinic (Solar) Keratosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Foamix Pharmaceuticals Ltd Product
Table 93. Foamix Pharmaceuticals Ltd Recent Development
Table 94. G&E Herbal Biotechnology Co Ltd Corporation Information
Table 95. G&E Herbal Biotechnology Co Ltd Description and Major Businesses
Table 96. G&E Herbal Biotechnology Co Ltd Actinic (Solar) Keratosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. G&E Herbal Biotechnology Co Ltd Product
Table 98. G&E Herbal Biotechnology Co Ltd Recent Development
Table 99. Galderma SA Corporation Information
Table 100. Galderma SA Description and Major Businesses
Table 101. Galderma SA Actinic (Solar) Keratosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Galderma SA Product
Table 103. Galderma SA Recent Development
Table 104. Laboratories Ojer Pharma SL Corporation Information
Table 105. Laboratories Ojer Pharma SL Description and Major Businesses
Table 106. Laboratories Ojer Pharma SL Actinic (Solar) Keratosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Laboratories Ojer Pharma SL Product
Table 108. Laboratories Ojer Pharma SL Recent Development
Table 109. LEO Pharma A/S Corporation Information
Table 110. LEO Pharma A/S Description and Major Businesses
Table 111. LEO Pharma A/S Actinic (Solar) Keratosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. LEO Pharma A/S Product
Table 113. LEO Pharma A/S Recent Development
Table 114. Novartis AG Corporation Information
Table 115. Novartis AG Description and Major Businesses
Table 116. Novartis AG Actinic (Solar) Keratosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Novartis AG Product
Table 118. Novartis AG Recent Development
Table 119. Oncology Research International Ltd Corporation Information
Table 120. Oncology Research International Ltd Description and Major Businesses
Table 121. Oncology Research International Ltd Actinic (Solar) Keratosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Oncology Research International Ltd Product
Table 123. Oncology Research International Ltd Recent Development
Table 124. Promius Pharma LLC Corporation Information
Table 125. Promius Pharma LLC Description and Major Businesses
Table 126. Promius Pharma LLC Actinic (Solar) Keratosis Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Promius Pharma LLC Product
Table 128. Promius Pharma LLC Recent Development
Table 129. Valeant Pharmaceuticals International Inc Corporation Information
Table 130. Valeant Pharmaceuticals International Inc Description and Major Businesses
Table 131. Valeant Pharmaceuticals International Inc Actinic (Solar) Keratosis Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Valeant Pharmaceuticals International Inc Product
Table 133. Valeant Pharmaceuticals International Inc Recent Development
Table 134. Vectura Group Plc Corporation Information
Table 135. Vectura Group Plc Description and Major Businesses
Table 136. Vectura Group Plc Actinic (Solar) Keratosis Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Vectura Group Plc Product
Table 138. Vectura Group Plc Recent Development
Table 139. Global Actinic (Solar) Keratosis Treatment Sales Forecast by Regions (2021-2026) (K Pcs)
Table 140. Global Actinic (Solar) Keratosis Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global Actinic (Solar) Keratosis Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global Actinic (Solar) Keratosis Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: Actinic (Solar) Keratosis Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 144. North America: Actinic (Solar) Keratosis Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: Actinic (Solar) Keratosis Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 146. Europe: Actinic (Solar) Keratosis Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: Actinic (Solar) Keratosis Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 148. Asia Pacific: Actinic (Solar) Keratosis Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: Actinic (Solar) Keratosis Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 150. Latin America: Actinic (Solar) Keratosis Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: Actinic (Solar) Keratosis Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 152. Middle East and Africa: Actinic (Solar) Keratosis Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key Actinic (Solar) Keratosis Treatment Players
Table 157. Actinic (Solar) Keratosis Treatment Customers List
Table 158. Actinic (Solar) Keratosis Treatment Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Actinic (Solar) Keratosis Treatment Product Picture
Figure 2. Global Actinic (Solar) Keratosis Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. 854-A Product Picture
Figure 4. ACT-01 Product Picture
Figure 5. AD-17137 Product Picture
Figure 6. Celecoxib Product Picture
Figure 7. DFD-08 Product Picture
Figure 8. GDC-695 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Actinic (Solar) Keratosis Treatment Sales Market Share by Application in 2020 & 2026
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Others
Figure 14. Actinic (Solar) Keratosis Treatment Report Years Considered
Figure 15. Global Actinic (Solar) Keratosis Treatment Market Size 2015-2026 (US$ Million)
Figure 16. Global Actinic (Solar) Keratosis Treatment Sales 2015-2026 (K Pcs)
Figure 17. Global Actinic (Solar) Keratosis Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Actinic (Solar) Keratosis Treatment Sales Market Share by Region (2015-2020)
Figure 19. Global Actinic (Solar) Keratosis Treatment Sales Market Share by Region in 2019
Figure 20. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Region (2015-2020)
Figure 21. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Region in 2019
Figure 22. Global Actinic (Solar) Keratosis Treatment Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Actinic (Solar) Keratosis Treatment Revenue in 2019
Figure 24. Actinic (Solar) Keratosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Actinic (Solar) Keratosis Treatment Sales Market Share by Type (2015-2020)
Figure 26. Global Actinic (Solar) Keratosis Treatment Sales Market Share by Type in 2019
Figure 27. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Type (2015-2020)
Figure 28. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Type in 2019
Figure 29. Global Actinic (Solar) Keratosis Treatment Market Share by Price Range (2015-2020)
Figure 30. Global Actinic (Solar) Keratosis Treatment Sales Market Share by Application (2015-2020)
Figure 31. Global Actinic (Solar) Keratosis Treatment Sales Market Share by Application in 2019
Figure 32. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Application (2015-2020)
Figure 33. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Application in 2019
Figure 34. North America Actinic (Solar) Keratosis Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Actinic (Solar) Keratosis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Actinic (Solar) Keratosis Treatment Sales Market Share by Country in 2019
Figure 37. North America Actinic (Solar) Keratosis Treatment Revenue Market Share by Country in 2019
Figure 38. U.S. Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Actinic (Solar) Keratosis Treatment Market Share by Type in 2019
Figure 43. North America Actinic (Solar) Keratosis Treatment Market Share by Application in 2019
Figure 44. Europe Actinic (Solar) Keratosis Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Actinic (Solar) Keratosis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Actinic (Solar) Keratosis Treatment Sales Market Share by Country in 2019
Figure 47. Europe Actinic (Solar) Keratosis Treatment Revenue Market Share by Country in 2019
Figure 48. Germany Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Actinic (Solar) Keratosis Treatment Market Share by Type in 2019
Figure 59. Europe Actinic (Solar) Keratosis Treatment Market Share by Application in 2019
Figure 60. Asia Pacific Actinic (Solar) Keratosis Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Actinic (Solar) Keratosis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Actinic (Solar) Keratosis Treatment Sales Market Share by Region in 2019
Figure 63. Asia Pacific Actinic (Solar) Keratosis Treatment Revenue Market Share by Region in 2019
Figure 64. China Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Actinic (Solar) Keratosis Treatment Market Share by Type in 2019
Figure 87. Asia Pacific Actinic (Solar) Keratosis Treatment Market Share by Application in 2019
Figure 88. Latin America Actinic (Solar) Keratosis Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Actinic (Solar) Keratosis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Actinic (Solar) Keratosis Treatment Sales Market Share by Country in 2019
Figure 91. Latin America Actinic (Solar) Keratosis Treatment Revenue Market Share by Country in 2019
Figure 92. Mexico Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Actinic (Solar) Keratosis Treatment Market Share by Type in 2019
Figure 99. Latin America Actinic (Solar) Keratosis Treatment Market Share by Application in 2019
Figure 100. Middle East and Africa Actinic (Solar) Keratosis Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Actinic (Solar) Keratosis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Actinic (Solar) Keratosis Treatment Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Actinic (Solar) Keratosis Treatment Revenue Market Share by Country in 2019
Figure 104. Turkey Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Actinic (Solar) Keratosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Actinic (Solar) Keratosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Actinic (Solar) Keratosis Treatment Market Share by Type in 2019
Figure 111. Middle East and Africa Actinic (Solar) Keratosis Treatment Market Share by Application in 2019
Figure 112. North America Actinic (Solar) Keratosis Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Actinic (Solar) Keratosis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Actinic (Solar) Keratosis Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Actinic (Solar) Keratosis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Actinic (Solar) Keratosis Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Actinic (Solar) Keratosis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Actinic (Solar) Keratosis Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Actinic (Solar) Keratosis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Actinic (Solar) Keratosis Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Actinic (Solar) Keratosis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
脂漏性角化症治療の世界市場（～2026年） Seborrheic keratosis is one of the common noncancerous skin growths in older adults. The growths mostly appear on shoulders, back, abdomen, face, chest, and scalp. Cryosurgery is the most preferred method to remove the growth. The method uses liquid nitrogen to freeze off the growth. The Americas do…- 脂漏性角化症の世界市場（～2026年） Seborrheic keratosis is one of the common noncancerous skin growths in older adults. The growths mostly appear on shoulders, back, abdomen, face, chest, and scalp. Cryosurgery is the most preferred method to remove the growth. The method uses liquid nitrogen to freeze off the growth. The Americas do…
- 屋上太陽光発電（PV）設置の世界市場（～2026年） A rooftop photovoltaic power station, or rooftop PV system, is a photovoltaic system that has its electricity-generating solar panels mounted on the rooftop of a residential or commercial building or structure. A rooftop photovoltaic power station, or rooftop PV system, is a photovoltaic system that…
- 代替太陽光発電用太陽電池技術の世界市場（～2026年） Photo voltaic cells convert solar light photons into electricity. Photovoltaic solar cells fulfill two functions: photogeneration of charge carriers (electrons and holes) in a light-absorbing material, and separation of the charge carriers to a conductive contact that will transmit the electricity. …
- ソーラーパネルリサイクル管理の世界市場（～2026年） Solar panels have a lifetime of about 30 years. With the increasing number of solar panels being sold and installed in the United States each year, it’s only a matter of time before high volumes of silicon solar panels are at the end of their useful life and have to be disposed of. Solar panel recyc…